Compound Detail
CHEMBL898
DIFLUNISAL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL898 |
| Name | DIFLUNISAL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | HUPFGZXOMWLGNK-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
10
Targets
36
Activities
4
Assay Types
10
PK Parameters
20
Publications
4
Known Names
6
Indications
1
Mechanisms
Molecular Properties
250.2
MW (Da)
3.04
ALogP
2
HBA
2
HBD
57.5
PSA (Ų)
0.86
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1982 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cyclooxygenase inhibitor | INHIBITOR | Cyclooxygenase | ✓ | ✓ |
Indications
Arthritis, Rheumatoid Fever Osteoarthritis Pain Amyloid Neuropathies, Familial Diabetes Mellitus, Type 2
ATC Classification
N02BA11
diflunisal
Level 1: NERVOUS SYSTEM
Level 2: ANALGESICS
Drug Warnings
Black Box Warning
cardiotoxicity
Black Box Warning
neurotoxicity
Black Box Warning
gastrointestinal toxicity
Activity Summary
IC50 15 meas. best 6.07
Kd 14 meas. best 7.12
Ki 6 meas. best 5.68
EC50 1 meas. best 5.25
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Transthyretin CHEMBL3194 | Kd | 7.12 | 6.0443 | 75.0 | 7 |
| Solute carrier family 22 member 6 CHEMBL1641347 | IC50 | 6.07 | 6.07 | 850.0 | 1 |
| Unchecked CHEMBL612545 | Kd | 5.94 | 5.94 | 1160.0 | 1 |
| Albumin CHEMBL3253 | Kd | 5.91 | 5.715 | 1230.3 | 2 |
| Transthyretin CHEMBL3194 | Ki | 5.68 | 5.68 | 2100.0 | 1 |
| 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase CHEMBL4105941 | Ki | 5.59 | 5.59 | 2560.0 | 1 |
| Carbonic anhydrase 2 CHEMBL205 | IC50 | 5.57 | 5.57 | 2700.0 | 1 |
| Carbonic anhydrase 1 CHEMBL261 | IC50 | 5.47 | 5.47 | 3380.0 | 1 |
| Transthyretin CHEMBL3194 | IC50 | 5.46 | 5.072 | 3500.0 | 5 |
| Transthyretin CHEMBL3194 | EC50 | 5.25 | 5.25 | 5600.0 | 1 |
| Carbonic anhydrase 1 CHEMBL261 | Ki | 5.07 | 5.07 | 8450.0 | 1 |
| Carbonic anhydrase 2 CHEMBL205 | Ki | 5.03 | 5.03 | 9370.0 | 1 |
| 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase CHEMBL4105941 | IC50 | 4.87 | 4.87 | 13500.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.75 | 4.75 | 18000.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.53 | 4.41 | 29800.0 | 2 |
| Dihydrofolate reductase CHEMBL202 | Ki | 4.47 | 4.47 | 34000.0 | 1 |
| Macrophage cell line CHEMBL613891 | IC50 | 4.28 | 4.28 | 53000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 0.18 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.31 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 10.23 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| Cmax | 200000.0 | nM | Homo sapiens |
| F | 80.0 | % | Homo sapiens |
| F | 100.0 | % | Homo sapiens |
| Fu | 0.0016 | - | Homo sapiens |
| MRT | 14.0 | hr | Homo sapiens |
| T1/2 | 10.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine